Solarea Bio appoints Catherine Balsam-Schwaber as CEO ahead of launch of first synbiotic for menopausal bone health
- bancheta6
- Oct 8
- 1 min read
Boston, MA, October 3, 2025 (PRNewswire) -- Solarea Bio announced the appointment of Catherine Balsam-Schwaber as Chief Executive Officer to lead its next growth phase and the upcoming commercial launch of Bondia™, a first-of-its-kind synbiotic medical food for postmenopausal bone health. Balsam-Schwaber, known for scaling mission-driven health companies such as Kindra and Thoughtful AI, succeeds co-founder Dr. Gerardo V. Toledo, who will remain as an advisor. Bondia™, set to launch this month, targets inflammation-driven bone loss through the gut-bone axis, aiming to benefit millions of women affected by osteoporosis-related conditions.
Read full article here.
Comments